Updates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomes.

作者: Giuseppe Gargiulo , Davide Capodanno , Giovanni Longo , Piera Capranzano , Corrado Tamburino

DOI: 10.1586/14779072.2014.964687

关键词:

摘要: NSAIDs are used worldwide by more than 30 million people everyday, given their anti-inflammatory, analgesic and antipyretic effects. approved for several common adult diseases, including acute chronic musculoskeletal or inflammatory disease, osteoarthritis, rheumatoid arthritis other arthritic conditions, as well children with juvenile idiopathic arthritis. Importantly, the population commonly taking is that of older individuals who also represent highest risk cardiovascular (CV) gastrointestinal adverse In recent years, a growing body evidence regarding potential risks from use has emerged. The aim this review to update available data concerning in patients without CV disease analyzing mechanisms action, interference specific established protective role low-dose aspirin, increased myocardial infarction, stroke, hypertension, heart failure atrial fibrillation.

参考文章(95)
H. Yokoyama, N. Ito, S. Soeda, M. Ozaki, Y. Suzuki, M. Watanabe, E. Kashiwakura, T. Kawada, N. Ikeda, K. Tokuoka, Y. Kitagawa, Y. Yamada, Influence of non-steroidal anti-inflammatory drugs on antiplatelet effect of aspirin Journal of Clinical Pharmacy and Therapeutics. ,vol. 38, pp. 12- 15 ,(2013) , 10.1111/J.1365-2710.2012.01373.X
Mai Duong, Francesco Salvo, Antoine Pariente, Abdelilah Abouelfath, Regis Lassalle, Cecile Droz, Patrick Blin, Nicholas Moore, Usage patterns of 'over-the-counter' vs. prescription-strength nonsteroidal anti-inflammatory drugs in France. British Journal of Clinical Pharmacology. ,vol. 77, pp. 887- 895 ,(2014) , 10.1111/BCP.12239
Manuela Weigl, Michael Gschwantler, Edmund Gatterer, Josef Finsterer, Claudia Stöllberger, Reflux esophagitis in the pathogenesis of paroxysmal atrial fibrillation: results of a pilot study. Southern Medical Journal. ,vol. 96, pp. 1128- 1132 ,(2003) , 10.1097/01.SMJ.0000084294.77504.4B
Cristina Varas‐Lorenzo, Nuria Riera‐Guardia, Brian Calingaert, Jordi Castellsague, Francesco Salvo, Federica Nicotra, Miriam Sturkenboom, Susana Perez‐Gutthann, Myocardial infarction and individual nonsteroidal anti‐inflammatory drugs meta‐analysis of observational studies Pharmacoepidemiology and Drug Safety. ,vol. 22, pp. 559- 570 ,(2013) , 10.1002/PDS.3437
Moti Rosenstock, Abraham Danon, Gilad Rimon, PGHS-2 inhibitors, NS-398 and DuP-697, attenuate the inhibition of PGHS-1 by aspirin and indomethacin without altering its activity Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. ,vol. 1440, pp. 127- 137 ,(1999) , 10.1016/S1388-1981(99)00105-5
Luis Alberto García Rodríguez, Stefania Tacconelli, Paola Patrignani, Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population. Journal of the American College of Cardiology. ,vol. 52, pp. 1628- 1636 ,(2008) , 10.1016/J.JACC.2008.08.041